Nascent Geographic Atrophy as a Predictor of Type 3 Macular Neovascularization Development-Reference-Cited by-同舟云学术

Nascent Geographic Atrophy as a Predictor of Type 3 Macular Neovascularization Development

Published:2023-07 Issue:7 Volume:7 Page:586-592
ISSN:2468-6530
Container-title:Ophthalmology Retina
language:en
Short-container-title:Ophthalmology Retina

Author:

Sacconi Riccardo,Sarraf David,Sadda SriniVas R.,Freund K. Bailey^ORCID,Servillo Andrea,Fogel Levin Meira Miri^ORCID,Costanzo Eliana^ORCID,Corradetti Giulia^ORCID,Cabral Diogo^ORCID,Zur Dinah^ORCID,Trivizki Omer^ORCID,Parravano Mariacristina,Bandello Francesco^ORCID,Loewenstein Anat^ORCID,Querques Giuseppe^ORCID

Publisher

Elsevier BV

Subject

Ophthalmology

Reference44 articles.

1. The incidence of neovascular subtypes in newly diagnosed neovascular age-related macular degeneration;Jung;Am J Ophthalmol,2014

2. Clinical classification of age-related macular degeneration;Ferris;Ophthalmology,2013

3. Comparison of age-related macular degeneration treatments trials (CATT) Research Group. Outcomes in eyes with retinal angiomatous proliferation in the comparison of age-related macular degeneration treatments trials (CATT);Daniel;Ophthalmology,2016

4. The rap study, report 5: rediscovering macular neovascularization type 3: multimodal imaging of fellow eyes over 24 months;Haj Najeeb;Retina,2022

5. Type 3 neovascularisation: long-term analysis of visual acuity and optical coherence tomography anatomical outcomes;Chae;Br J Ophthalmol,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural OCT and OCT angiography biomarkers associated with the development and progression of geographic atrophy in AMD;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-04-30

2. The potential key role of choroidal non-perfusion and rod degeneration in the pathogenesis of macular neovascularization type 3;Eye;2024-03-18

3. Distinct Pathways of Macular Atrophy in Type 3 Macular Neovascularization Associated With AMD;Investigative Opthalmology & Visual Science;2024-03-12

4. FROM DRUSEN TO TYPE 3 MACULAR NEOVASCULARIZATION;Retina;2024-02

5. Functional and structural characteristics in patients with type 3 macular neovascularisation treated with anti-VEGF. Three-year results in real world settings;Eye;2024-01-06